We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Funding Awarded to COVID-19 Clinical Study Targeting Angiotensin Receptor

News   Jun 01, 2020 | Original story from Vicore Pharma

 
Funding Awarded to COVID-19 Clinical Study Targeting Angiotensin Receptor

Credit: rawpixel

 
 
Advertisement
 

RELATED ARTICLES

New Cancer Vaccine Ready for Human Trials

News

A new cancer vaccine, comprised of human antibodies fused with tumor-specific protein, is ready to begin human testing.

READ MORE

Success in Use of Nanoparticles To Deliver Gene Therapy for Eye Disease in Rodents

News

In experiments in rats and mice, scientists report the successful use of nanoparticles to deliver gene therapy for blinding eye disease.

READ MORE

A Mirror-image Peptide Tumor Treatment

News

Scientists have developed a new approach to immunological tumor treatment. Their method is based on the specific blockade of an immune checkpoint by a stable "mirror-image" peptide.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE